ImmuCell Corporation (ICCC) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
ImmuCell Corporation (ICCC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $97.1M, listed on NASDAQ, employing roughly 73 people, carrying a beta of 0.57 to the broader market. ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U. Led by F. Olivier Te Boekhorst, public since 1987-05-05.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for ICCC as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.